市場調査レポート
商品コード
1587465

マイクロキャリアの市場規模、シェア、動向分析レポート:消耗品別、用途別、最終用途別、地域別、セグメント別予測、2025年~2030年

Microcarriers Market Size, Share & Trends Analysis Report By Consumable (Media & Reagents, Microcarrier Beads), By Application (Biopharmaceutical Production, Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
マイクロキャリアの市場規模、シェア、動向分析レポート:消耗品別、用途別、最終用途別、地域別、セグメント別予測、2025年~2030年
出版日: 2024年10月22日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マイクロキャリア市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のマイクロキャリア市場規模は、2025年から2030年にかけて10.49%のCAGRを記録し、2030年までに35億米ドルに達すると予測されています。

同市場の成長は、細胞培養製品の需要の高まり、世界の疾病負担の増大、希少疾患の新たな治療法を特定・開発するための集中的な研究開発活動への絶え間ない投資、細胞生物学などの先端研究で採用される技術の継続的な開発によってもたらされる4。

COVID-19が大流行する中、市場は前向きな成長を遂げました。SARS-CoV2ウイルスのワクチンを発見し開発しようとする科学者や研究者の絶え間ない努力の結果、ヘルスケア企業と学術機関の両方による研究開発の規模が拡大しました。研究活動の活発化、巨額の資金調達、治療用製品に対する需要の高まりが、市場の成長をもたらしました。さらに、ウイルスベクターをベースとしたワクチンの開発には、マイクロキャリア細胞培養を使用して可能なウイルスの効率的な生産が必要です。例えば、コペンハーゲン大学の科学者たちは、2021年6月に発表した研究論文で、SARS-CoV2ウイルスがキャリアビーズを充填したシングルユース・バイオリアクター内のVero細胞で効率的に生産されたことを実証しました。このような発見がCOVID-19ワクチン生産を後押しし、市場成長をさらに促進しています。

さらに、接着細胞製造のマトリックスとしてマイクロキャリアの使用率が高く、これらの小さな球状ビーズがあらゆる規模の商業生産で使用されているため、市場空間は急速に拡大しています。悪性疾患や希少疾患の治療のために、細胞治療や遺伝子治療、ウイルスワクチン、モノクローナル抗体などの革新的な治療オプションの需要が増加しているため、バイオ医薬品の生産能力が増加しています。例えば、ファイザー社は2021年12月、6,850万米ドルを投資し、米国ノースカロライナ州に新施設を開設したと発表しました。この拡張により、同社は遺伝子治療能力の強化に注力し、血友病AおよびB、DMD(デュシェンヌ型筋ジストロフィー)、ALS(筋萎縮性側索硬化症)、その他多くの神経疾患、内分泌疾患、代謝性疾患に対するポートフォリオを臨床開発しています。このようなバイオ医薬品や再生医療の開発のための投資の増加は、市場の成長を促進すると予想されます。

さらに、細胞生物学に基づく研究には、新しい治療法を開発するための徹底的な研究開発が含まれます。しかし、こうした取り組みには、細胞株、培地、装置、その他マイクロキャリア培養のための関連製品への投資が必要であり、そのため莫大な資金が必要となります。予算の制約がある研究機関や新興企業は、治療薬開発のための細胞ベースの研究を制限すると思われます。したがって、細胞培養製品の採用が減り、成長が抑制されます。しかし、新薬生産に向けた政府の取り組みや、主要企業との提携・提携は、投資を緩和し、市場成長を高めることができます。

マイクロキャリア市場のレポートハイライト

  • 消耗品別では、マイクロキャリアビーズが2024年に64.46%のシェアで大きく貢献することが確認されました。細胞培養におけるマイクロキャリアビーズの使用が拡大し続けていることが、同市場で最も高い収益を生み出す要因となっています。
  • 用途別では、感染症や遺伝性疾患の増加、がん罹患率の増加により、安全で効果的な医薬品や治療法の製造需要が高まっていることから、バイオ医薬品製造分野が2024年に71.81%の最大シェアを獲得しました。
  • 製薬・バイオテクノロジー企業セグメントは、2024年に43.95%で最大の市場シェアを獲得し、予測期間中に大きく成長すると予測されています。
  • 北米は2024年に41.11%のシェアを獲得し、最も高い収益を上げました。同地域では慢性疾患や感染症が急増しており、高度な治療が必要とされています。
  • アジア太平洋地域は、高齢者人口が最も多いことに加え、国内市場での生物製剤需要の増加と経済成長の影響を受けています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 マイクロキャリア市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 マイクロキャリア市場:消耗品の推定・動向分析

  • 消耗品の変動分析と市場シェア、2024年と2030年
  • 市場推計・予測、2018年から2030年
  • 培地と試薬
  • マイクロキャリアビーズ
    • コラーゲンコーティングビーズ
    • カチオンビーズ
    • タンパク質コーティングビーズ
    • 未処理ビーズ
    • その他

第5章 マイクロキャリア市場:用途の推定・動向分析

  • 用途の変動分析と市場シェア、2024年と2030年
  • 市場推計・予測、2018年から2030年
  • バイオ医薬品製造
    • ワクチン製造
    • 治療薬の製造
  • 再生医療

第6章 マイクロキャリア市場:最終用途の推定・動向分析

  • 最終用途変動分析と市場シェア、2024年と2030年
  • 市場推計・予測、2018年から2030年
  • 製薬・バイオテクノロジー企業
  • CROとCMO
  • 学術研究機関

第7章 マイクロキャリア市場:消耗品、用途、最終用途別の地域推定・動向分析

  • 地域ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年:
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析、2024年
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Danaher Corporation
    • Sartorius AG
    • Corning Incorporated
    • Eppendorf SE
    • Bio-Rad Laboratories, Inc.
    • HiMedia Laboratories Pvt. Ltd.
    • DenovoMATRIX GmbH
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 3 North America Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 6 U.S. Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Canada Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 9 Canada Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Mexico Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 12 Mexico Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 15 Europe Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 17 UK Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 18 UK Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 19 UK Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 21 Germany Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Germany Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 23 France Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 24 France Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 25 France Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Italy Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 27 Italy Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Spain Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 30 Spain Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Denmark Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 33 Denmark Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 34 Denmark Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Sweden Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 36 Sweden Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Sweden Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 39 Norway Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Japan Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 45 Japan Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 48 China Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 49 China Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 51 India Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 52 India Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 54 Australia Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 57 South Korea Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 60 Thailand Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 63 Latin America Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Brazil Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 66 Brazil Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 67 Brazil Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Argentina Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 69 Argentina Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 70 Argentina Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 71 MEA Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 72 MEA Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 73 MEA Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 74 South Africa Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 75 South Africa Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 76 South Africa Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 80 UAE Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 81 UAE Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 82 UAE Microcarriers Market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Kuwait Microcarriers Market, by consumable, 2018 - 2030 (USD Million)
  • Table 84 Kuwait Microcarriers Market, by application, 2018 - 2030 (USD Million)
  • Table 85 Kuwait Microcarriers Market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Microcarriers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 13 Global Microcarriers Market, Consumable Outlook: Key Takeaways
  • Fig. 14 Global Microcarriers Market: Consumable Movement Analysis
  • Fig. 15 Global Microcarriers Market, for Media & Reagents, 2018 - 2030 (USD Million)
  • Fig. 16 Global Microcarriers Market, for Microcarrier Beads, 2018 - 2030 (USD Million)
  • Fig. 17 Global Microcarriers Market, Application Outlook: Key Takeaways
  • Fig. 18 Global Microcarriers Market: Application Movement Analysis
  • Fig. 19 Global Microcarriers Market, for Biopharmaceutical Production, 2018 - 2030 (USD Million)
  • Fig. 20 Global Microcarriers Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
  • Fig. 21 Global Microcarriers Market, End Use Outlook: Key Takeaways
  • Fig. 22 Global Microcarriers Market: End Use Movement Analysis
  • Fig. 23 Global Microcarriers Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 24 Global Microcarriers Market, for Contract Research Organizations & Contract Manufacturing Organizations, 2018 - 2030 (USD Million)
  • Fig. 25 Global Microcarriers Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Global Microcarriers Market: Region Movement Analysis
  • Fig. 28 North America Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 35 France Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 38 Demark Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 40 Norway Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 43 China Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 44 India Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 45 Australia Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Microcarriers Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Microcarriers Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-991-5

Microcarriers Market Growth & Trends:

The global microcarriers market size is expected to reach USD 3.50 billion by 2030, registering a CAGR of 10.49% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is driven by the rising demand of cell-cultured products, the growing burden of diseases worldwide, constant investments for intensive R&D activities to identify and develop new treatments for rare disorders, and the continuous developments in technologies employed in advanced research such as cell-biology.4

Amidst the COVID-19 pandemic, the market witnessed a positive growth. The continuous strive of scientist and researchers to find and develop vaccines for the SARS-CoV2 virus resulted in scaling up of R&D efforts by both healthcare companies and academic institutes. The increased research activities, huge funding, and growing demand of therapeutic products resulted in the growth of the market. Moreover, development of viral vectors based vaccines requires efficient production of viruses which is possible using microcarriers cell-culture. For instance, scientists from University of Copenhagen demonstrated in their research article published in June 2021 that SARS-CoV2 virus was efficiently produced in Vero cells in a single-use bioreactors packed with carrier beads. Findings like these have boosted the COVID-19 vaccine production further propelling market growth.

Moreover, the marketspace is rapidly expanding owing to the high usage of microcarriers as matrix for adherent cell manufacturing and these small spherical beads are used across all scales of commercial production. The increasing demand of innovative therapeutic options such as cell and gene therapy, viral vaccines, and monoclonal antibodies for treatment of malignant and rare diseases has resulted in increase in the biopharmaceutical production capacities. For example, Pfizer Inc., announced in December 2021 that it has invested USD 68.5 million and opened a new facility in North Carolina, USA. With the expansion the company is focused on enhancing its gene therapy capabilities and clinically develops its portfolio for hemophilia A and B, DMD (Duchenne muscular dystrophy), ALS (amyotrophic lateral sclerosis) and many more neurologic, endocrine as well as metabolic diseases. Such increased investments for development of biopharmaceuticals and regenerative medicines are expected to propel the market growth.

Furthermore, cell-biology based research involves exhaustive R&D for developing new therapies. But these efforts require investments for cell lines, media, equipment and other related products for microcarriers culture and thus requires huge influx of money. Institutes and emerging players with budget constraints will limit the cell based research for therapeutics development. Hence, it will decrease the adoption of cell-culture products and restrain the growth. However, government initiatives for novel drug production and collaboration & partnerships with key players can offer investment relief and enhance the market growth.

Microcarriers Market Report Highlights:

  • By consumables, microcarrier beads was identified as the larger contributor with 64.46% share in 2024. The ever-expanding use of microcarrier beads during cell culture contributes to the highest revenue generation in the market.
  • By application, the biopharmaceutical production segment captured the largest market share 71.81%, in 2024, due to the growing cases of infectious diseases & genetic disorders and increasing cancer incidence, resulting in increasing demand for producing safe & effective medicines or treatments.
  • The pharmaceutical & biotechnology companies segment captured the largest market share at 43.95% in 2024 and is anticipated to grow significantly over the forecast period.
  • North America generated the highest revenue with a 41.11% share in 2024. The area is witnessing a surge in chronic and infectious diseases, necessitating advanced medical treatments
  • Asia Pacific region is primarily influenced by the increasing demand for biologics within its domestic market and the growth of its economies, alongside having the highest population of seniors

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definition
    • 1.2.1. Consumable
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
  • 1.7. Primary Research
  • 1.8. Information or Data Analysis
  • 1.9. Market Formulation & Validation
  • 1.10. Market Model
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Microcarriers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High demand of cell based vaccines & therapeutics
      • 3.2.1.2. Increasing incidence of various diseases & disorders
      • 3.2.1.3. Huge investments for development of innovative therapies
      • 3.2.1.4. Consistent technological advancements in cell biology research
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of research for cell based drug and therapy
      • 3.2.2.2. High cost of downstream processing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Microcarriers Market: Consumable Estimates & Trend Analysis

  • 4.1. Consumable Movement Analysis & Market Share, 2024 & 2030
  • 4.2. Microcarriers Market Estimates & Forecast, By Consumable, 2018 to 2030 (USD Million)
  • 4.3. Media and Reagents
    • 4.3.1. Media and Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Microcarrier Beads
    • 4.4.1. Microcarrier Beads Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Collagen Coated Beads
      • 4.4.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Cationic Beads
      • 4.4.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Protein Coated Beads
      • 4.4.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Untreated Beads
      • 4.4.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Microcarriers Market: Application Estimates & Trend Analysis

  • 5.1. Application Movement Analysis & Market Share, 2024 & 2030
  • 5.2. Microcarriers Market Estimates & Forecast, By Consumable, 2018 to 2030 (USD Million)
  • 5.3. Biopharmaceutical Production
    • 5.3.1. Biopharmaceutical Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Vaccine Production
      • 5.3.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Therapeutic Production
      • 5.3.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Regenerative Medicine
    • 5.4.1. Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Microcarriers Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Movement Analysis & Market Share, 2024 & 2030
  • 6.2. Microcarriers Market Estimates & Forecast, By Consumable, 2018 to 2030 (USD Million)
  • 6.3. Pharmaceutical & Biotechnology Companies
    • 6.3.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. CROs & CMOs
    • 6.4.1. CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Microcarriers Market: Regional Estimates & Trend Analysis by Consumable, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. Key company market share analysis, 2024
    • 8.2.2. Thermo Fisher Scientific, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Merck KGaA
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Danaher Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Sartorius AG
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Corning Incorporated
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Eppendorf SE
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Bio-Rad Laboratories, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. HiMedia Laboratories Pvt. Ltd.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. DenovoMATRIX GmbH
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives